C
Crisantaspase
Availability of ACE Drug Guidance
No
Biologics Drug Information Overview
Yes
Subsidy Information and Financing Scheme
Cancer Drug and Clinical Indication listed in the MediShield Life Outpatient Cancer Drug List
Active ingredient: Crisantaspase
General information
Subsidy Information and Financing Scheme
[MSHL] Crisantaspase Injection 10,000 international units
For cancer treatment in patients who have developed hypersensitivity to E.coli-derived asparaginase.
Drug Guidance for Subsidy
Not Applicable
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Erwinase Injection 10,000 international units |
|